Skip to main content
Log in

Investigational New Drugs

Novel Anti-Cancer Therapeutics and Therapies

Publishing model:

Overview

Investigational New Drugs is a forum for rapid dissemination of information on new anticancer agents.

  • The journal publishes original articles dealing with anticancer drug development.
  • It provides the fastest possible publication of new discoveries for scientists developing anticancer agents.
  • The journal also publishes proceedings of special workshops and symposia on anticancer drug development.
  • It is open to publishing clinical trials with negative results if they contribute to the understanding of investigational agents.
  • 100% of authors surveyed would likely publish in the journal again.
Editor-in-Chief
  • Eric K. Rowinsky

Journal metrics

Journal Impact Factor
2.7 (2024)
5-year Journal Impact Factor
3.2 (2024)
Submission to first decision (median)
5 days
Downloads
461.8k (2024)

Latest articles

Journal updates

Journal information

Electronic ISSN
1573-0646
Print ISSN
0167-6997
Abstracted and indexed in
  1. BFI List
  2. BIOSIS
  3. Baidu
  4. Biological Abstracts
  5. CLOCKSS
  6. CNKI
  7. CNPIEC
  8. Chemical Abstracts Service (CAS)
  9. Cortellis Drug Discovery Intelligence
  10. Current Contents/Clinical Medicine
  11. Current Contents/Life Sciences
  12. Dimensions
  13. EBSCO
  14. EMBASE
  15. Google Scholar
  16. Japanese Science and Technology Agency (JST)
  17. Medline
  18. Naver
  19. OCLC WorldCat Discovery Service
  20. Pathway Studio
  21. Portico
  22. ProQuest
  23. Reaxys
  24. SCImago
  25. SCOPUS
  26. Science Citation Index Expanded (SCIE)
  27. Semantic Scholar
  28. TD Net Discovery Service
  29. Wanfang
  30. eLibrary.ru
© Springer Science+Business Media, LLC, part of Springer Nature

Journal navigation